These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

444 related items for PubMed ID: 26722466

  • 1. Semaphorin-3F functions as a tumor suppressor in colorectal cancer due to regulation by DNA methylation.
    Gao X, Tang C, Shi W, Feng S, Qin W, Jiang T, Sun Y.
    Int J Clin Exp Pathol; 2015; 8(10):12766-74. PubMed ID: 26722466
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. NGX6 gene mediated by promoter methylation as a potential molecular marker in colorectal cancer.
    Liu M, Peng Y, Wang X, Guo Q, Shen S, Li G.
    BMC Cancer; 2010 Apr 27; 10():160. PubMed ID: 20423473
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The oncogenic role of LncRNA FAM83C-AS1 in colorectal cancer development by epigenetically inhibits SEMA3F via stabilizing EZH2.
    Xue W, Wang F, Han P, Liu Y, Zhang B, Gu X, Wang Y, Li M, Zhao Y, Cui B.
    Aging (Albany NY); 2020 Oct 27; 12(20):20396-20412. PubMed ID: 33109776
    [Abstract] [Full Text] [Related]

  • 6. Semaphorin-3F suppresses the stemness of colorectal cancer cells by inactivating Rac1.
    Rao J, Zhou ZH, Yang J, Shi Y, Xu SL, Wang B, Ping YF, Chen L, Cui YH, Zhang X, Wu F, Bian XW.
    Cancer Lett; 2015 Mar 01; 358(1):76-84. PubMed ID: 25529012
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer.
    Tang JT, Wang JL, Du W, Hong J, Zhao SL, Wang YC, Xiong H, Chen HM, Fang JY.
    Carcinogenesis; 2011 Aug 01; 32(8):1207-15. PubMed ID: 21665895
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. SP1 mediates the link between methylation of the tumour suppressor miR-149 and outcome in colorectal cancer.
    Wang F, Ma YL, Zhang P, Shen TY, Shi CZ, Yang YZ, Moyer MP, Zhang HZ, Chen HQ, Liang Y, Qin HL.
    J Pathol; 2013 Jan 01; 229(1):12-24. PubMed ID: 22821729
    [Abstract] [Full Text] [Related]

  • 10. Promoter methylation and expression of SOCS-1 affect clinical outcome and epithelial-mesenchymal transition in colorectal cancer.
    Kang XC, Chen ML, Yang F, Gao BQ, Yang QH, Zheng WW, Hao S.
    Biomed Pharmacother; 2016 May 01; 80():23-29. PubMed ID: 27133036
    [Abstract] [Full Text] [Related]

  • 11. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
    Galamb O, Kalmár A, Barták BK, Patai ÁV, Leiszter K, Péterfia B, Wichmann B, Valcz G, Veres G, Tulassay Z, Molnár B.
    World J Gastroenterol; 2016 Dec 21; 22(47):10325-10340. PubMed ID: 28058013
    [Abstract] [Full Text] [Related]

  • 12. Epigenetic silencing of LRRC3B in colorectal cancer.
    Tian XQ, Zhang Y, Sun D, Zhao S, Xiong H, Fang J.
    Scand J Gastroenterol; 2009 Dec 21; 44(1):79-84. PubMed ID: 18815942
    [Abstract] [Full Text] [Related]

  • 13. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V, Lentjes MH, van den Bosch SM, Hellebrekers DM, de Hoon JP, Wouters KA, Daenen KL, Partouns-Hendriks IE, Stessels F, Louwagie J, Smits KM, Weijenberg MP, Sanduleanu S, Khalid-de Bakker CA, Oort FA, Meijer GA, Jonkers DM, Herman JG, de Bruïne AP, van Engeland M.
    J Natl Cancer Inst; 2009 Jul 01; 101(13):916-27. PubMed ID: 19535783
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Aberrant methylation and silencing of the BNIP3 gene in colorectal and gastric cancer.
    Murai M, Toyota M, Suzuki H, Satoh A, Sasaki Y, Akino K, Ueno M, Takahashi F, Kusano M, Mita H, Yanagihara K, Endo T, Hinoda Y, Tokino T, Imai K.
    Clin Cancer Res; 2005 Feb 01; 11(3):1021-7. PubMed ID: 15709167
    [Abstract] [Full Text] [Related]

  • 17. Involvement of methylation-associated silencing of formin 2 in colorectal carcinogenesis.
    Li DJ, Feng ZC, Li XR, Hu G.
    World J Gastroenterol; 2018 Nov 28; 24(44):5013-5024. PubMed ID: 30510376
    [Abstract] [Full Text] [Related]

  • 18. KISS1 methylation and expression as predictors of disease progression in colorectal cancer patients.
    Chen SQ, Chen ZH, Lin SY, Dai QB, Fu LX, Chen RQ.
    World J Gastroenterol; 2014 Aug 07; 20(29):10071-81. PubMed ID: 25110434
    [Abstract] [Full Text] [Related]

  • 19. DNA hypermethylation and decreased mRNA expression of MAL, PRIMA1, PTGDR and SFRP1 in colorectal adenoma and cancer.
    Kalmár A, Péterfia B, Hollósi P, Galamb O, Spisák S, Wichmann B, Bodor A, Tóth K, Patai ÁV, Valcz G, Nagy ZB, Kubák V, Tulassay Z, Kovalszky I, Molnár B.
    BMC Cancer; 2015 Oct 19; 15():736. PubMed ID: 26482433
    [Abstract] [Full Text] [Related]

  • 20. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J, Luo RZ, Fujii S, Wang L, Hu W, Andreeff M, Pan Y, Kadota M, Oshimura M, Sahin AA, Issa JP, Bast RC, Yu Y.
    Cancer Res; 2003 Jul 15; 63(14):4174-80. PubMed ID: 12874023
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.